Glycopyrrolate Oral Solution
NDC 70010-106, Glycopyrrolate, solution, from Granules Pharmaceuticals Inc..
- Product NDC
- 70010-106
- Status
- Listed
- Labeler
- Granules Pharmaceuticals Inc.
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214735
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70010-106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLYCOPYRROLATE1 mg/5mL
Pharmacologic classes
Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70010-106-44 | 70010010644 | 473 mL in 1 BOTTLE (70010-106-44) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0f05c5d3-9c41-4dae-88d1-18cbddc69487
Use it
Look up 70010-106 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70010-106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70010-106. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.